Circrisa IV infusion 100mg, manufactured by Sanofi, contains isatuximab (genetical recombination). This injectable drug (YJ code: 4291454A1021) is supplied as 100mg in 5mL per bottle and is indicated for the treatment of multiple myeloma. Note: “Circrisa” is also known as Sarclisa.
Circrisa IV infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →